Pre-seed to growth fund research profile
Aroa Venture Partners is an India-focused venture manager backing founders from pre-seed through growth, with a growing emphasis on research-led deep technology. The manager combines early capital with hands-on commercialisation support across AI, energy, climate, healthcare, spacetech and related frontier technologies.
At a glance
Research profile
Open a section to inspect the evidence. The first view starts with the investment point of view; the rest stays quiet until you need it.
Investment lens
Aroa Venture Partners uses a pre-seed to growth; deep tech approach across AI and enterprise software, climate and energy, healthcare and spacetech.
Current evidence
Aroa’s 2026 portfolio page documents the first cohort of its India Deep Tech Accelerator with the University of Chicago Polsky Center, including Augle.AI, BioSky Space Innovations, Cerify, MedevPlus, Nuevata, Pradivya, Project DART, Torus Motion, TriNANO and Zodhya. The manager also reports a 2025 CoreOps.AI investment and a 2025 Passprt Trips investment.
Bundled fund series
Related manager and vehicle records are shown here as one fund family. The original source trails and vehicle-level caveats remain preserved in the research record.
Aroa Venture Partners Fund II
Vintage / record year: 2022
Strategy
Pre-seed to growth; deep tech
Sector focus
AI and enterprise software, climate and energy, healthcare and spacetech
AIF structure context
Indian venture capital and angel-fund strategies are commonly structured as Category I AIFs. Verify the specific vehicle and registration before investing.
Current signal
Aroa’s 2026 portfolio page documents the first cohort of its India Deep Tech Accelerator with the University of Chicago Polsky Center, including Augle.AI, BioSky Space Innovations, Cerify, MedevPlus, Nuevata, Pradivya, Project DART, Torus Motion, TriNANO and Zodhya. The manager also reports a 2025 CoreOps.AI investment and a 2025 Passprt Trips investment.
Investor questions
Aroa Venture Partners is covered in Rupeia's venture capital research universe. The current public record describes the strategy as Pre-seed to growth; deep tech, with a sector focus of AI and enterprise software, climate and energy, healthcare and spacetech. The profile should be read with the linked source trail and Typical route: Category I AIF context.
The profile displays only company or asset names attributable to Aroa Venture Partners in the reviewed public sources: Pine Labs, CRED, Cars24, Urban Company, MPL, Zetwerk, Miko, Orange Health Labs, Freight Tiger, Dataweave, Kawa Space, Presentations.ai, ClearDekho, Jobizo, CoreOps.AI, Passprt Trips, C-Zentrix, Samarth Elder Care, CION Cancer Clinics, CoreOps AI, Pavakah Energy, The manager’s current portfolio page lists five Fund II companies: Samarth Elder Care, CoreOps AI and Pavakah Energy.. It does not represent a complete current portfolio unless the manager has published one.
Aroa’s public portfolio page identifies more than 40 investments and multiple exits, including Urban Company, Orange Health Labs, Presentations.ai, Edmingle and TangoEye. Recent 2025–2026 activity includes CoreOps.AI, Passprt Trips, C-Zentrix and the India Deep Tech Accelerator. These signals are not a substitute for fund- and vintage-specific net performance, realised distributions and audited or administrator-supported reporting.
Public fund size: Fund-level corpus is not publicly disclosed in the current manager materials; Fund II is identified as a SEBI Category II AIF.. Public terms or access information: Pre-seed to Series C venture investing, with a deep-tech and India-to-global orientation. Public materials do not disclose fees, carry, reserves or standard cheque sizes.. Current fees, minimum commitment and availability must be confirmed for the exact named vehicle in its fund documents.
The current source record names Gaurav Gulati (Founder and Managing Partner); Nitin Wadhwa (GP, Fund II); Sekhar Puli (GP, Fund II); Pakhi Chaturvedi, PhD (Associate Vice President). Verify current roles, departures, attribution and key-person provisions before relying on the team history for a new commitment.
Review stage concentration, follow-on reserves, company failure rates, dilution, exit timing and the gap between paper valuations and realised distributions. The current open diligence point is: Fund-level return reporting and detailed Fund II terms are not publicly disclosed; the manager operates both venture funds and an accelerator, so vehicle-level attribution is retained where the public record identifies it. Vehicle-level differences from Aroa Venture Partners Fund II are retained in seriesRecords; the directory publishes one manager-level record..
2026-02-17: Aroa’s 2026 portfolio page documents the first cohort of its India Deep Tech Accelerator with the University of Chicago Polsky Center, including Augle.AI, BioSky Space Innovations, Cerify, MedevPlus, Nuevata, Pradivya, Project DART, Torus Motion, TriNANO and Zodhya. The manager also reports a 2025 CoreOps.AI investment and a 2025 Passprt Trips investment.
Next step
Share the allocation question, ticket size, liquidity constraints and existing exposure. Rupeia can determine whether this profile needs a deeper decision-support brief.